Announcements Trials

Browse Landscape

Phase

Status

Completed 80 Unknown 13 Terminated 11 Withdrawn 4 Suspended 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Lung Neoplasms 1

Interventions

Cisplatin 3 pembrolizumab 2 Etoposide 2 Docetaxel 2 Carboplatin 2 durvalumab 1 Specimen Handling 1 Radiotherapy 1 Radiosurgery 1 Radionuclide Imaging 1 Radiation 1 Prednisone 1 Positron-Emission Tomography 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Injections 1 Exercise Therapy 1 Erlotinib Hydrochloride 1 Eflornithine 1 Clinical Protocols 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 Biopsy 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Lung Neoplasms × Erlotinib Hydrochloride × Clear all

NCT01320501 2016-05-13

REALME

National Guard Health Affairs

Phase 4 Suspended

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡